跳至主要内容
临床试验/IRCT2016022625481N2
IRCT2016022625481N2已完成未知

Investigation of preoperative oral Tizanidine on blood loss in endoscopic sinus surgery

Vice Chancellor for research of Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
All

入选标准

  • Age more than 16 years undergoing endoscopic sinus surgery • ASA class I and II
  • Exclusion criteria : • high blood pressure (severe) • liver or kidney disease •coagulopathy • Diabetes • Abnormal blood sugar on the morning of the day of surgery • severe hypotension during surgery that requires intravenous administration of large volumes • Lack of consent to participate in the study have. Aspirin or any anticoagulants drugs. hemoglobin under 10.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Mashhad University of Medical Sciences

相似试验